1、 Development history of DR equipment

DR equipment, also known as direct digital X-ray photography system, is composed of electronic cassette, scanning controller, system controller, image monitor, etc. It directly converts X-ray photons into digital images through electronic cassette, and is a generalized direct digital X-ray photography. In a narrow sense, direct digital radiography, also known as DDR, usually refers to digital radiography using image conversion technology using flat panel detectors, and is a true direct digital X-ray photography system. Ordinary X-ray machines have gone through the development process from film machines, CR, CCD-DR to flat DR.

Development history of DR equipment

Source: Medical Device Home, organized by Huajing Industry Research Institute

2、 Market size of medical imaging equipment in China

Medical imaging equipment is the market segment with the highest technical barriers in the medical device industry. With the rapid development of China's economy and the worsening problem of population aging, the public's awareness of health has increased, and the demand for healthcare services continues to increase. The demand for high-quality medical imaging in the domestic market has correspondingly grown rapidly. Driven by market demand and policy dividends, the Chinese medical imaging equipment market will continue to grow, with a market size of 53.7 billion yuan in 2020 and an expected market size of 53.53 billion yuan in 2021.

The size and growth rate of China's medical imaging equipment market from 2015 to 2021

​

Source: Compilation of public information

Related report: "2021-2026 China DR Equipment Industry Development Monitoring and Investment Strategy Planning Research Report" released by Huajing Industry Research Institute

3、 Analysis of the Competitive Landscape of China's DR Equipment Market

1. Regional competitive landscape

From the perspective of DR equipment procurement volume in various provinces and cities in China, according to statistics, Guangdong ranked first in the list of DR procurement quantity provinces/municipalities in 2021, followed by Henan, Shandong, Jiangsu, Hunan, Hebei, Zhejiang, Sichuan, Anhui, and Shanxi.

Top 10 on the 2021 China DR Procurement Provincial/Municipal Rankings

​

Source: Medical procurement, organized by Huajing Industrial Research Institute

2. Competitive landscape in the conventional DR market

In terms of sales volume, domestic brands have taken the lead, with Wandong ranking first at 20.11%, followed by Anjian 9.42%, Lianying 8.03%, Puai 7.58%, Lanying 5.98%, Mindray 5.53%, Shentu 4.75%, Philips 4.63%, Siemens 4.51%, and Ruike 4.42%, which have basically achieved domestic substitution.

Market share of conventional DR brand sales in China in 2021 (unit:%)

​

 

Source: Medical procurement, organized by Huajing Industrial Research Institute

In terms of sales amount, Wandong still ranks first with a proportion of 13.45%. However, due to the higher price of imported brands compared to domestic brands, Wandong is followed by Philips 10.11%, followed by Siemens 9.16%, Shimadzu 8.98%, Lianying 8.89%, Anjian 7.73%, Ruike 7.13%, GE6.57%, Puai 5.07%, and Mindray 4.50%.

Market share of conventional DR brand sales in China in 2021 (unit:%)

​

 

Source: Medical procurement, organized by Huajing Industrial Research Institute

3. Analysis of the Competition Pattern in the Mobile DR Market

Since the outbreak of the COVID-19 epidemic, the demand for mobile DR has continued to rise. In the mobile DR market in 2021, domestic brands have already occupied a considerable market share, and the trend of substitution is irreversible. In terms of sales volume, the top 5 brands are all domestic brands, with Lianying accounting for 16.62%, followed by Wandong accounting for 13.38%, Mindray 10.29%, Anjian 9.71%, and Puai 8.24%.

Market share of China's mobile DR brand sales in 2021 (unit:%)

​

 

Source: Medical procurement, organized by Huajing Industrial Research Institute

In terms of sales amount, Lianying has the largest market share, reaching 19.38%. Next are Mindray (12.75%), Wandong (10.57%), Anjian (7.67%), and Ruike (6.39%).

Market share of China's mobile DR brand sales in 2021 (unit:%)

​

 

Source: Medical procurement, organized by Huajing Industrial Research Institute

4. Analysis of the Competition Pattern in the Breast DR Market

In terms of sales volume of breast DR in 2021, the domestic brand Lianying still ranked first with a proportion of 17.96%. However, compared to conventional DR and mobile DR, foreign manufacturers accounted for the majority of the market share. Foreign brands also rank among the top in terms of sales revenue, with Haoluojie accounting for 22.27% and leading the list, followed by GE accounting for 18.48%, and Lianying ranking third.

Market share of breast DR brand sales in China in 2021 (unit:%)

​

Source: Medical procurement, organized by Huajing Industrial Research Institute

Market share of breast DR brand sales in China in 2021 (unit:%)

​

 

Source: Medical procurement, organized by Huajing Industrial Research Institute

4、 Analysis of the Development Trend of DR Equipment in China

1. Domestic substitution acceleration

During the 13th Five Year Plan period, China's medical device industry has made significant progress in the field of medical imaging diagnostic equipment, and domestic products have been widely recognized by hospital users. Among them, the market sales of domestic digital X-ray machines (DR) are close to 70%, surpassing imported brands. In the future, the DR market will enter a development platform period, and the total demand for new and updated products will remain at a certain level;

2. Medical imaging equipment is developing towards miniaturization, intelligence, and low-cost

In 2020, the FDA approved the world's first mobile magnetic resonance imaging device, which reduced the testing cost to 1/20 compared to traditional MR. With the continuous growth of demand for medical imaging equipment in China, the shortage of medical talents is difficult to alleviate in the short term. Portable, intelligent, and low-cost medical imaging equipment will comply with the national graded diagnosis and treatment policy and become the future development trend.

3. Multimodal fusion and integrated diagnosis and treatment of medical imaging equipment

The future medical imaging equipment industry should not only provide high-performance medical imaging equipment for medical institutions, but also assist doctors in developing integrated diagnostic and treatment solutions, with the ultimate goal of reducing patient treatment costs and improving treatment efficiency. Therefore, multimodal integration and diagnosis and treatment integration are the main development directions of the industry in the future, and more medical imaging diagnosis and treatment equipment with multimodal functions will be pushed to the market.

Huajing Intelligence Network is affiliated with the Huajing Industry Research Institute and focuses on industrial economic intelligence and research in the Greater China region. Currently, its main products and services include traditional and emerging industry research, business plans, feasibility studies, market research, special reports, customized reports, etc. It covers the fields of culture and sports, logistics and tourism, health care for the elderly, biomedicine, energy and chemical industry, equipment manufacturing, automotive electronics, agriculture, forestry, animal husbandry and fishery, and also deeply studies emerging fields such as smart city, smart life, smart manufacturing, new energy, new materials, new consumption, new finance, artificial intelligence, and "Internet plus".